LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 175 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $3,160,000 | +17.2% | 59,384 | +3.4% | 0.13% | +20.0% |
Q3 2014 | $2,697,000 | +229.7% | 57,404 | +337.1% | 0.10% | +228.1% |
Q2 2014 | $818,000 | -78.3% | 13,134 | -81.7% | 0.03% | -80.6% |
Q4 2013 | $3,766,000 | +101.6% | 71,596 | +65.9% | 0.16% | +68.4% |
Q3 2013 | $1,868,000 | – | 43,153 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |